Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
Thomas R. Lane, Julie Dyall, Mercer Luke, et al.
Antiviral Research (2020) Vol. 182, pp. 104908-104908
Open Access | Times Cited: 25

Showing 25 citing articles:

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
Ana C. Puhl, Ethan J. Fritch, Thomas R. Lane, et al.
ACS Omega (2021) Vol. 6, Iss. 11, pp. 7454-7468
Open Access | Times Cited: 65
Artesunate—multiple pharmacological effects beyond treating malaria
Yuan‐Shiun Chang, Tong Lyu, Xiaojie Luan, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117292-117292
Closed Access
Machine Learning Models Identify Inhibitors of SARS-CoV-2
Victor O. Gawriljuk, Phyo Phyo Kyaw Zin, Ana C. Puhl, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4224-4235
Open Access | Times Cited: 43
Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites
Siennah R. Miller, Meghan E. McGrath, Kimberley M. Zorn, et al.
Molecular Pharmacology (2021) Vol. 100, Iss. 6, pp. 548-557
Open Access | Times Cited: 34
Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review
Lin Guan, Huiyong Wang, Xiaolong Xu, et al.
Advanced Biology (2023) Vol. 7, Iss. 8
Closed Access | Times Cited: 9
The Antiviral Drug Tilorone Is a Potent and Selective Inhibitor of Acetylcholinesterase
Patricia A. Vignaux, Eni Minerali, Thomas R. Lane, et al.
Chemical Research in Toxicology (2021) Vol. 34, Iss. 5, pp. 1296-1307
Open Access | Times Cited: 23
Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade
Mateus Sá Magalhães Serafim, Valtair Severino dos Santos, Jadson Castro Gertrudes, et al.
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 9, pp. 961-975
Closed Access | Times Cited: 19
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
Ana C. Puhl, Ethan J. Fritch, Thomas R. Lane, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 16
Defending Antiviral Cationic Amphiphilic Drugs That May Cause Drug-Induced Phospholipidosis
Thomas R. Lane, Sean Ekins
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4125-4130
Open Access | Times Cited: 14
Strategies in Medicinal Chemistry to Discover New Hit Compounds against Ebola Virus: Challenges and Perspectives in Drug Discovery
Igor José dos Santos Nascimento, Paulo Fernando da Silva Santos-Júnior, João Xavier de Araújo‐Junior, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 22, pp. 2896-2924
Closed Access | Times Cited: 10
Incidence, toxin gene profile, antibiotic resistance and antibacterial activity of Allium parvum and Allium cepa extracts on Bacillus cereus isolated from fermented millet-based food
Akhila Etikala, S. Thamburaj, Anju Mariam Johnson, et al.
LWT (2022) Vol. 160, pp. 113314-113314
Open Access | Times Cited: 9
EBOLApred: A machine learning-based web application for predicting cell entry inhibitors of the Ebola virus
Joseph Adams, Kwasi Agyenkwa-Mawuli, Odame Agyapong, et al.
Computational Biology and Chemistry (2022) Vol. 101, pp. 107766-107766
Closed Access | Times Cited: 8
The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
Ana C. Puhl, Thomas R. Lane, Fabio Urbina, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 8
Multiple approaches to repurposing drugs for neuroblastoma
Laura Rank, Ana C. Puhl, Tammy M. Havener, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117043-117043
Open Access | Times Cited: 7
Learning from COVID-19: How drug hunters can prepare for the next pandemic
Ana C. Puhl, Thomas R. Lane, Sean Ekins
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103723-103723
Open Access | Times Cited: 3
Repurposing drugs targeting epidemic viruses
Vigneshwaran Namasivayam, Palaniappan Senthilkumar, Murugesan Vanangamudi
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1874-1894
Closed Access | Times Cited: 6
Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
Patricia A. Vignaux, Thomas R. Lane, Ana C. Puhl, et al.
ACS Omega (2023) Vol. 8, Iss. 13, pp. 12532-12537
Open Access | Times Cited: 2
Machine Learning in Discovery of New Antivirals and Optimization of Viral Infections Therapy
Olga Tarasova, Vladimir Poroikov
Current Medicinal Chemistry (2021) Vol. 28, Iss. 38, pp. 7840-7861
Closed Access | Times Cited: 6
Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and Cancer
Ana C. Puhl, Renuka Raman, Tammy M. Havener, et al.
ACS Omega (2024) Vol. 9, Iss. 10, pp. 11870-11882
Open Access
Inter-Species Pharmacokinetic Modeling and Scaling for Drug Repurposing of Pyronaridine and Artesunate
Dong Wook Kang, Ju Hee Kim, Kyung‐Min Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6998-6998
Open Access
Current updates on the epidemiology, pathogenesis and development of small molecule therapeutics for the treatment of Ebola virus infections
Shah Alam Khan, Neelima Shrivastava, Md Jawaid Akhtar, et al.
Asian Pacific Journal of Tropical Medicine (2024) Vol. 17, Iss. 7, pp. 285-298
Open Access
Repurposing Drugs and Synergistic Combinations as Potential Therapies for Inhibiting SARS-CoV-2 and Coronavirus Replication
Richard Boulon, Clément Mazeaud, Majid D. Farahani, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 4043-4055
Open Access
Exploring the druggability of the UEV domain of human TSG101 in search for broad-spectrum antivirals
Fernando Montero, Marisa Parra‐López, Alejandro Rodríguez‐Martínez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Exploring the druggability of the UEV domain of human TSG101 in search for broad‐spectrum antivirals
Fernando Montero, Marisa Parra‐López, Alejandro Rodríguez‐Martínez, et al.
Protein Science (2024) Vol. 34, Iss. 1
Open Access
Tilorone-Dihydrochloride Protects against Rift Valley Fever Virus Infection and Disease in the Mouse Model
Kendra N. Johnson, Birte Kalveram, Jennifer K. Smith, et al.
Microorganisms (2021) Vol. 10, Iss. 1, pp. 92-92
Open Access | Times Cited: 4
Page 1

Scroll to top